                                  SCHEDULE 14A


                            SCHEDULE 14A INFORMATION
               Proxy Statement Pursuant to Section 14(a) of the
                         Securities Exchange Act of 1934

Filed by the Registrant    [X]

Filed by Party other than the Registrant    [  ]

Check the appropriate box:

[ ]   Preliminary Proxy Statement
[ ]   Confidential,  for Use of the  Commission  Only  (as  permitted  by Rule
      14a-6(e)(2))
[X]   Definitive Proxy Statement
[ ]   Definitive Additional Materials
[ ]   Soliciting Material Pursuant to ss.240.14a-12


                              ADVANTEGO CORPORATION
                    ---------------------------------------
                (Name of Registrant as Specified In Its Charter)

                    William T. Hart - Attorney for Registrant
                   (Name of Person(s) Filing Proxy Statement)


Payment of Filing Fee (Check the appropriate box):

[X] No fee required.

[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1) Title of each class of securities to which transaction applies:

---------------------------------------------------

(2)   Aggregate number of securities to which transaction applies:

---------------------------------------------------

(3) Per unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was determined):

------------------------------------------------------------------------------

                                       1
<PAGE>

(4) Proposed maximum aggregate value of transaction:

---------------------------------------------------

(5) Total fee paid:

---------------------------------------------------

[ ] Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange Act
    Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
    paid previously. Identify the previous filing by registration statement
    number, or the Form or Schedule and the date of its filing.

(1) Amount Previously Paid:

---------------------------------------------------

(2)   Form, Schedule or Registration Statement No.:

---------------------------------------------------

(3)   Filing Party:

---------------------------------------------------

(4)   Date Filed:

---------------------------------------------------



                                       2
<PAGE>


                              ADVANTEGO CORPORATION
                             1 Park Plaza, Suite 600
                                Irvine, CA 92614
                                 (949) 627-8977

                    NOTICE OF SPECIAL MEETING OF STOCKHOLDERS

To the Stockholders:

      Notice is hereby given that a special meeting of the stockholders (the
"Meeting") of Advantego Corporation, a Colorado corporation (the "Company") will
be held on March 6, 2020 at 10:00 AM (Pacific Time) at 1 Park Plaza, Suite 600,
Large Conference Room, Irvine, CA 92614 for the following purposes:

(1)  to approve amendments to the Company's Articles of Incorporation;

     i.   to reduce the quorum required at shareholders' meetings; and

     ii.  to allow shareholders  owning a majority of the Company's  outstanding
          shares to approve actions without a meeting;

(2)  to approve a reverse split of the Company's common stock,  should the board
     of  directors  believe this to be in the best  interests  of the  Company's
     shareholders,  in a ratio that will be determined by the Company's board of
     directors.

(3)  to approve an  amendment  to the  Company's  Articles of  Incorporation  to
     increase the Company's authorized  capitalization to 300,000,000,000 shares
     of common stock.

     January 20, 2020 is the record date for the determination of stockholders
entitled to notice of and to vote at the Meeting (the "Record Date"). Holders of
the Company's common stock, and Series B preferred stock are entitled to one
vote per share at the special meeting of shareholders. Holders of the Company's
Series A preferred stock are entitled to 1,000 votes per share at the special
meeting of shareholders.

      Shareholders of the Company owning all of the outstanding shares of the
Company's Series A preferred stock (two persons) intend to one vote in favor of
the proposal to come before the meeting.

                                       ADVANTEGO CORPORATION

January 20, 2020                       Robert W. Ferguson
                                       Chief Executive Officer


                                       3
<PAGE>


                    PLEASE INDICATE YOUR VOTING INSTRUCTIONS
                           ON THE ATTACHED PROXY CARD,
                    AND SIGN, DATE AND RETURN THE PROXY CARD.
                    TO SAVE THE COST OF FURTHER SOLICITATION,
                              PLEASE VOTE PROMPTLY.

                              ADVANTEGO CORPORATION
                             1 Park Plaza, Suite 600
                                Irvine, CA 92614
                                 (949) 627-8977

                                 PROXY STATEMENT

     The accompanying  proxy is solicited by the Company's  directors for voting
at the special  meeting of  shareholders  to be held on March 6, 2020 and at all
adjournments of such meeting. If the proxy is executed and returned,  it will be
voted  at  the  meeting  in  accordance  with  any   instructions,   and  if  no
specification is made, the proxy will be voted for the proposal set forth in the
accompanying  notice of the special meeting of  shareholders.  Shareholders  who
execute  proxies may revoke  them at any time  before they are voted,  either by
writing to the  Company at the  address  shown above or in person at the time of
the meeting.  Additionally,  any later dated proxy will revoke a previous  proxy
from the same  shareholder.  This proxy  statement  was posted on the  Company's
website on or about January 20, 2020.

     As of January 20, 2020 the Company had:

     1)   710,375,804 outstanding shares of common stock, with each common share
          entitled to one vote at the special meeting;

     2)   100,000  outstanding  shares of Series A  preferred  stock,  with each
          share entitled to 1,000 votes at the special meeting; and

     3)   240,000 outstanding shares of Series B preferred stock with each share
          entitled to one vote at the special meeting.

     Provided a quorum  consisting of a majority of the shares  entitled to vote
is present at the  meeting,  the  adoption of the  proposals  to come before the
meeting will be approved if the votes cast in favor of the  proposal  exceed the
votes cast against the proposal.

     Shares of the  Company's  common  stock  represented  by properly  executed
proxies  that  reflect  abstentions  or  "broker  non-votes"  will be counted as
present for  purposes  of  determining  the  presence of a quorum at the special
meeting.  "Broker  non-votes"  represent  shares  held  by  brokerage  firms  in
"street-name"  with  respect to which the broker has not  received  instructions
from the customer or otherwise  does not have  discretionary  voting  authority.
Abstentions and broker non-votes will not be counted as having voted against the
proposal to be considered at the meeting.


                                       4
<PAGE>

                             PRINCIPAL SHAREHOLDERS

    The following table lists, as of January 20, 2020 the shareholdings of (i)
each person owning beneficially 5% or more of the Company's common stock; (ii)
each executive officer and director of the Company, and (iii) all officers and
directors as a group. Unless otherwise indicated, each owner has sole voting and
investment power over his shares of common stock.

      Name and Address                Number of Shares        Percent of Class

      Robert W. Ferguson                4,576,454                  0.06%
      1 Park Plaza, Suite 600
      Irvine, CA 92614

      Fred Popke                        4,651,454                  0.07%
      1 Park Plaza, Suite 600
      Irvine, CA 92614

      Tracy A. Madsen                      64,795                    NIL
      17 N. Foxhill Rd.
      North Salt Lake, UT 84054

      All Officers and Directors        9,292,703                 0.013%
      as a group (3 persons)

      The following table lists, as of January 20, 2020 the shareholdings of
each person owning the Company's Series A preferred stock. Unless otherwise
indicated, each owner has sole voting and investment power over his shares of
preferred stock:

      Name and Address              Number of Shares (1)     Percent of Class
      ----------------              --------------------     ----------------

      Robert W. Feguson                   500,000                    50%
      1 Park Plaza, Suite 600
      Irvine, CA 92614

      Fred Popke                          500,000                    50%
      1 Park Plaza, Suite 600
      Irvine, CA 92614

(1)  Each  Series  A  preferred  share  is  convertible  into  one  share of the
     Company's  common  stock  and is  entitled  to 1,000  votes  on any  matter
     submitted to the Company's shareholders.



                                       5
<PAGE>


      The following table lists, as of January 20, 2020 the shareholdings of
each person owning the Company's Series B preferred stock. Unless otherwise
indicated, each owner has sole voting and investment power over his shares of
preferred stock:

      Name and Address                Number of Shares (1)     Percent of Class
      ----------------                ----------------         ----------------

      Steve Olson                          30,000                    13%
      30-4 Woodland Hills Drive
      Southgate, Kentucky 41071

      Joseph Smith                         25,000                    10%
      725 College Terrace
      Niagara Falls, NY 14305

      Stuart Rubin                         25,000                    10%
      5876 N.W. 54th Circle
      Coral Springs, FL 33067

      Robert W. Feguson                    80,000                    33%
      1 Park Plaza, Suite 600
      Irvine, CA 92614

      Fred Popke                           80,000                    33%
      1 Park Plaza, Suite 600
      Irvine, CA 92614

(1)  Each Series B preferred share is convertible into one-half of a share of
     the Company's common stock and is entitled to one vote on any matter
     submitted to the Company's shareholders.

                          PROPOSAL TO REDUCE THE QUORUM
                       REQUIRED AT SHAREHOLDERS' MEETINGS

     The Colorado Business Corporation (the "BCA") provides that a quorum at any
meeting  of a  corporation's  shareholders,  unless  otherwise  provided  in the
Articles of  Incorporation,  must be a majority of the votes entitled to be cast
at the meeting.  A  corporation's  Articles of  Incorporation  may provide for a
lesser  number,  provided  that a quorum  may not be less  than one third of the
shares entitled to be cast at any meeting.

     The  Company's  Articles of  Incorporation  do not  contain  any  provision
regarding a quorum  being less than a majority of the votes  entitled to be cast
at the meeting.

     Over 50% of the Company's  outstanding  shares are held in the nominee name
of the Depository Trust Company (i.e., in "street name"). Since the shareholders
who actually own these shares are not "shareholders of record",  the shares must
be voted  through  brokers,  banks or other  nominees.  Obtaining  the  votes of
shareholders  whose  shares are held in street  name is  difficult,  and in some
cases  corporations  are required to hire proxy  solicitors  to obtain the votes
needed for a quorum.  To avoid the time and effort needed to obtain a quorum for


                                       6
<PAGE>

any meeting of the Company's  shareholders,  the Company's  directors  recommend
that the Company's  Articles of Incorporation be amended by adding the following
to Article Fourth of the Articles of Incorporation:

     The presence in person,  or by proxy, of one-third of the votes entitled to
be cast on any matter by a voting group at any shareholders' meeting constitutes
a quorum of that voting group for action on that matter.

     The Company's Board of Directors recommends that stockholders vote FOR this
proposal.

                     PROPOSAL TO ALLOW SHAREHOLDERS OWNING A
                  MAJORITY OF THE COMPANY'S OUTSTANDING SHARES
                      TO APPROVE ACTIONS WITHOUT A MEETING

     Any action required or permitted to be taken at a shareholders' meeting may
be taken without a meeting if the Company's  Articles of  Incorporation  provide
that the shareholders  holding shares having not less than the minimum number of
votes that would be  necessary to take such action at a meeting (at which all of
the shares  entitled to vote were  present and voted)  consent to such action in
writing.

     The Company's Articles of Incorporation do not contain any such provisions.

     Allowing  shareholders  to take action  without a meeting saves the Company
the time and expense of holding a  shareholders'  meeting  when the action to be
taken at the meeting would be approved in any event.

     Accordingly,  the Company's directors recommend that the Company's Articles
of  Incorporation  be amended by adding the  following to Article  Fourth of the
Articles of Incorporation:

     Any action required or permitted to be taken at a shareholders' meeting may
be taken without a meeting if  shareholders  holding shares having not less than
the  minimum  number of votes that would be  necessary  to take such action at a
meeting  (at which all of the shares  entitled  to vote were  present and voted)
consent to such action in writing.

     If the proposal to increase the Company's  capitalization is approved,  the
Amendment  to the  Company's  Articles  of  Incorporation,  a copy of  which  is
attached to this proxy statement,  will be filed with the Colorado  Secretary of
State.

     The Company's Board of Directors recommends that stockholders vote FOR this
proposal.


                                       7
<PAGE>


              PROPOSAL TO APPROVE A REVERSE SPLIT OF THE COMPANY'S
            COMMON STOCK, SHOULD THE BOARD OF DIRECTORS BELIEVE THIS
            TO BE IN THE BEST INTERESTS OF ADVANTEGO'S SHAREHOLDERS,
                       IN A RATIO THAT WILL BE DETERMINED
                      BY THE COMPANY'S BOARD OF DIRECTORS.

     The  Company's  common  stock  trades on the OTCQB tier of the OTC  Markets
Group. Among other requirements,  a stock must have a minimum bid price of $0.01
to be eligible  to trade on the OTCQB  tier.  As of January 20, 2020 the closing
price of the Company's common stock was approximately  $0.001. In addition,  the
closing price of the  Company's  common stock has been less than $0.01 per share
since September 19, 2019.

     In  an  effort  to  increase  the  price  of  the  Company's  common  stock
stockholders  are being  requested to approve a reverse split of the outstanding
shares of the  Company's  common stock by a ratio that will be determined by the
Company's  Board of Directors,  provided  that,  in any case,  the reverse split
ratio will not be greater than 400 for 1. The  Company's  Board of Directors has
not made any determination as to whether it will actually proceed with a reverse
split of the  Company's  common  stock;  it is only  seeking  the  shareholders'
approval for such a step at this time.  The  Company's  Directors  believe that,
since it is not possible to predict future market conditions, it would be in the
best  interests of the  stockholders  to adopt a reverse  split of the Company's
outstanding common stock that allows the Board of Directors to determine whether
or not to proceed  with a stock split and if so, to  determine  the ratio of the
stock split.  The proposed  reverse  stock split would combine a whole number of
outstanding shares of the Company's common stock into one share of common stock,
thus reducing the number of outstanding shares without any corresponding  change
in the Company's par value.  As a result,  the number of shares of the Company's
common stock owned by each  stockholder  would be reduced in the same proportion
as the  reduction  in the  total  number  of  shares  outstanding,  so that  the
percentage  of the  outstanding  shares owned by each  stockholder  would remain
unchanged.

     The Company's Board of Directors reserves the right, even after stockholder
approval,  to forego the reverse stock split if it determines such action is not
in  the  Company's  best  interests  or the  best  interests  of  the  Company's
stockholders.  If the reverse  split is  abandoned,  the Board of Directors  may
again seek stockholder approval at a future date for a reverse stock split if it
deems a reverse  stock split to be advisable at that time.  If the reverse stock
split is adopted,  there will be no change in the number of authorized shares of
the Company's common stock. The primary reason for the reverse split stock is to
increase the trading price of the Company's common stock, by reducing the number
of the Company's  outstanding  shares,  and  increasing the number of shares the
Company can issue in the future.

     While the Company  expects that the reverse  stock split will  increase the
market price of its common stock,  the Company cannot guarantee that the reverse
stock split will  increase  the market  price of its common  stock by a multiple
equal to the reverse  split ratio,  or result in any  permanent  increase in the
market price, which can be dependent upon many factors, including


                                       8
<PAGE>


     the Company's business and financial performance and prospects.  Should the
market price decline after the reverse stock split,  the percentage  decline may
be greater, due to the smaller number of shares outstanding,  than it would have
been  prior to the  reverse  stock  split.  In some  cases  the  stock  price of
companies that have adopted  reverse stock splits has  subsequently  declined to
pre-reverse   split  levels.   Accordingly,   the  Company   cannot  assure  its
shareholders  that the market  price of its common stock  immediately  after the
effective  date of the reverse stock split will be maintained  for any period of
time,  or that the reverse  stock  split will not have an adverse  effect on the
Company's  stock price. A reverse stock split is often viewed  negatively by the
market and, consequently, can lead to a decrease in the Company's overall market
capitalization.  If the per share price does not increase  proportionately  as a
result of the reverse stock split, the Company's  overall market  capitalization
will be reduced.

     The  Company's  Articles  of  Incorporation  provide  that the  Company  is
presently authorized to issue 15,000,000,000 shares of common stock. The reverse
split,  if adopted,  would not change the number of shares of common stock which
the Company is  authorized to issue.  However,  a reverse split would reduce the
number of the Company's  outstanding  shares,  which would enable the Company to
issue more shares  than it would be able to issue if the  reverse  split was not
adopted.

     Notwithstanding  that above,  as of the date of this proxy  statement,  the
Company did not have any definitive agreements,  arrangements, plans, intentions
or commitments, written or oral, with any person to sell or issue any additional
shares of its  common  stock,  whether  for cash or  otherwise,  except  for the
Company's  obligation  to issue common  stock upon the  exercise of  outstanding
options and warrants or the conversion of notes.

     The Company would still have  approximately  1,300  shareholders  after the
reverse stock split and would continue to be registered  under Section 12 of the
Securities Exchange Act of 1934.

     The Company will pay $0.001 for any  fractional  share  resulting  from the
reverse stock split. To obtain payment, send a request to the Company at:

           Advantego Corporation
           c/o Chief Executive Officer
           1 Park Plaza, Suite 600
           Irvine, CA 92614

      Include in your request the name in which your shares are registered and
your address.

     If the reverse  split is adopted,  shareholders  owning less than one share
after the adoption of the reverse split are entitled to Dissenter's Rights under
Colorado law. See Dissenter's Rights below.

     The Company's Board of Directors recommends that stockholders vote FOR this
proposal.


                                       9
<PAGE>


PROPOSAL TO INCREASE THE AUTHORIZED COMMON STOCK OF THE COMPANY

     As of January  20,  2020 the  Company  was  authorized  to issue 15 billion
shares  of  Common  Stock  and there  were  710,375,804  shares of Common  Stock
outstanding,  with approximately 44 billion shares needed to be reserved for the
issuance upon conversion of outstanding  notes.  The agreements with most of the
holders of the Company's  convertible  notes require the Company to reserve with
its transfer agent a multiple of the shares which the Company may be required to
issue upon the  conversion of the notes.  As of January 20, 2020 the Company was
required to reserve for issuance approximately 221 billion shares.  However, the
actual  number of shares  which the  Company  would be  required  to issue as of
January  20,  2020  upon  the  conversion  of all  outstanding  notes  would  be
approximately 44 billion shares of common stock.

     Consequently, the Company does not have sufficient shares to meet the share
reserve  requirements  as provided by the terms of its agreements  with the note
holders.

     As a general matter,  the Board of Directors does not believe the currently
available  number of unissued  shares of Common  Stock is an adequate  number of
shares to assure that there will be sufficient  shares available for issuance in
connection  with  possible   future   acquisitions,   equity  and   equity-based
financings,   possible  future  awards  under  employee  benefit  plans,   stock
dividends,  stock splits, and other corporate purposes.  Therefore, the Board of
Directors  has approved the increase in  authorized  shares of Common Stock as a
means of providing the Company with the  flexibility  to act with respect to the
issuance  of  either  the  Common  Stock  or  securities   exercisable  for,  or
convertible into Common Stock in  circumstances  which they believe will advance
the interests of the Company and its  stockholders  without the delay of seeking
an amendment to the Articles of Incorporation at that time.

     The Company currently does not have sufficient funds to fund operations and
pay its debt obligations as they become due. As a result, the Board of Directors
is  considering,  and will  continue to  consider,  various  financing  options,
including  the issuance of Common Stock or  securities  convertible  into Common
Stock from time to time to raise  additional  capital  necessary  to support the
future growth of the Company. As a result of the increase in authorized capital,
the Board of Directors  will have more  flexibility to pursue  opportunities  to
engage in possible future capital market transactions  involving Common Stock or
other securities convertible into Common Stock,  including,  without limitation,
public  offerings  or private  placements  of such  Common  Stock or  securities
convertible  into Common  Stock.  With the  increase  to 300  billion  shares of
authorized  Common Stock the Company could raise  substantial  funds through the
issuance  of  convertible  debt  to  help  fund  operations  and  pay  its  debt
obligations.   The  issuance  of  such  convertible  notes  and  the  subsequent
conversion  by those  noteholders  could cause the Company to issue  substantial
shares of its Common Stock, causing dilution to existing shareholders.

     The additional  shares of Common Stock which may be authorized for issuance
may be issued for any proper purpose from time to time upon authorization by the
Board of Directors, without further approval by the stockholders unless required
y applicable law, rule or regulation,  including,  without limitation, rules of
any trading  market that the  Company's  Common Stock may trade on at that time.

                                       10
<PAGE>

b
Shares  may be  issued  for such  consideration  as the Board of  Directors  may
determine and as may be permitted by applicable law.

     The increase in the authorized shares of Common Stock is not intended to be
as a means of  preventing  or  dissuading a change in control or takeover of the
Company. However, use of these shares for such a purpose is possible. Authorized
but unissued or unreserved shares of Common Stock, for example,  could be issued
in an effort to dilute the stock  ownership and voting power of persons  seeking
to obtain  control  of the  Company or could be issued to  purchasers  who would
support the Board of Directors in opposing a takeover proposal. In addition, the
increase  in  authorized   shares  of  Common  Stock  may  have  the  effect  of
discouraging  a  challenge  for  control  or  make it less  likely  that  such a
challenge,  if  attempted,  would be  successful.  The  Board of  Directors  and
executive  officers of the Company have no  knowledge  of any current  effort to
obtain control of the Company or to accumulate large amounts of Common Stock.

     The  holders of Common  Stock are not  entitled to  preemptive  rights with
respect to the issuance of  additional  Common Stock or  securities  convertible
into or exercisable for Common Stock.

     The  holders  of  Common  Stock  will not  realize  any  dilution  in their
percentage of ownership of our company or their voting rights as a result of the
increase.  However,  issuances of  significant  numbers of additional  shares of
Common Stock in the future (i) will dilute stockholders' percentage ownership of
our  company  and (ii) if such  shares are issued at prices  below what  current
stockholders   paid  for  their   shares,   may  dilute  the  value  of  current
stockholders' shares.

     The  increase  in  authorized  capital  will not  change  the  terms of the
Company's  outstanding  Common  Stock.  The  additional  Common  Stock for which
authorization is sought will have the same voting rights and liquidation rights,
the same rights to  dividends  and  distributions  and will be  identical in all
other respects to the Common Stock now authorized.

     The Company is presently authorized to issue 10,000,000 shares of preferred
stock,  If adopted,  the proposal to increase the number of common  shares which
the  Company is  authorized  to issue will not have any effect on the  Company's
preferred stock.

     If the proposal to increase the Company's  capitalization is approved,  the
Amendment  to the  Company's  Articles  of  Incorporation,  a copy of  which  is
attached to this proxy statement,  will be filed with the Colorado  Secretary of
State.

     No dissenters'  or appraisal  rights under Colorado law are afforded to the
Company's  stockholders  as a result  of the  approval  of the  increase  in the
authorized capital.

     The Company's Board of Directors recommends that stockholders vote FOR this
proposal.

WHERE YOU CAN FIND MORE INFORMATION

     The Company is subject to the  informational  requirements  of the Exchange
Act and files reports and other information with the SEC. Such reports and other


                                       11
<PAGE>

information filed by the Company may be inspected and copied at the SEC's Public
Reference Room at 100 F Street, N.E., Washington,  D.C.20549,  as well as in the
SEC's public reference rooms in New York, New York and Chicago, Illinois. Please
call the SEC at 1-800-SEC-0330  for further  information on the operation of the
SEC's public  reference  rooms.  The SEC also  maintains  an Internet  site that
contains reports, proxy statements and other information about issuers, like us,
who file  electronically  with the SEC.  The  address  of the  SEC's web site is
http://www.sec.gov.

GENERAL

     The  cost  of   preparing,   printing  and  mailing  the  enclosed   proxy,
accompanying notice and proxy statement,  and all other costs in connection with
solicitation  of proxies will be paid by the Company.  Failure of a quorum to be
present at the meeting will necessitate adjournment and will subject the Company
to additional expense.

     The  Company's  Board of Directors  does not intend to present and does not
have reason to believe  that others will  present any other items of business at
the annual  meeting.  However,  if other  matters are properly  presented to the
meeting for a vote,  the proxies will be voted upon such  matters in  accordance
with the judgment of the persons acting under the proxies.



                                       12
<PAGE>


                   PROVISIONS PERTAINING TO DISSENTER'S RIGHTS
              Title 7, Article 113 of the Colorado Revised Statutes

7-113-101. Definitions. For purposes of this article:

     (1) "Beneficial shareholder" means the beneficial owner of shares held in a
voting trust or by a nominee as the record shareholder.

     (2) "Corporation" means the issuer of the shares held by a dissenter before
the  corporate  action,  or the  surviving  or  acquiring  domestic  or  foreign
corporation, by merger or share exchange of that issuer.

     (3)  "Dissenter"  means a  shareholder  who is  entitled  to  dissent  from
corporate  action under section  7-113-102  and who exercises  that right at the
time and in the manner required by part 2 of this article.

     (4) "Fair value", with respect to a dissenter's shares,  means the value of
the shares  immediately  before the effective  date of the  corporate  action to
which the dissenter  objects,  excluding any  appreciation  or  depreciation  in
anticipation  of the corporate  action except to the extent that exclusion would
be inequitable.

     (5)  "Interest"  means  interest from the  effective  date of the corporate
action  until the date of payment,  at the average  rate  currently  paid by the
corporation  on its  principal  bank  loans  or, if none,  at the legal  rate as
specified in section 5-12-101, C.R.S.

     (6)  "Record  shareholder"  means  the  person  in whose  name  shares  are
registered in the records of a  corporation  or the  beneficial  owner of shares
that are  registered  in the  name of a  nominee  to the  extent  such  owner is
recognized  by the  corporation  as  the  shareholder  as  provided  in  section
7-107-204.

     (7)  "Shareholder"  means  either  a  record  shareholder  or a  beneficial
shareholder.

7-113-102.    Right to dissent.

      (1) A shareholder, whether or not entitled to vote, is entitled to dissent
and obtain payment of the fair value of the shareholder's shares in the event of
any of the following corporate actions:

     (a)  Consummation  of a plan of merger to which the  corporation is a party
          if:

            (I)   Approval by the shareholders of that corporation is required
                  for the merger by section 7-111-103 or 7-111-104 or by the
                  articles of incorporation; or

            (II)  The corporation is a subsidiary that is merged with its parent
                  corporation under section 7-111-104;

      (b)  Consummation of a plan of share exchange to which the corporation is
           a party as the corporation whose shares will be acquired;

      (c)  Consummation of a sale, lease, exchange, or other disposition of all,
           or substantially all, of the property of the corporation for which a
           shareholder vote is required under section 7-112-102(1); and

                                       13
<PAGE>

      (d)  Consummation of a sale, lease, exchange, or other disposition of all,
           or substantially all, of the property of an entity controlled by the
           corporation if the shareholders of the corporation were entitled to
           vote upon the consent of the corporation to the disposition pursuant
           to section 7-112-102(2).

     (1.3) A shareholder  is not entitled to dissent and obtain  payment,  under
subsection (1) of this section,  of the fair value of the shares of any class or
series of shares  which  either  were listed on a national  securities  exchange
registered under the federal  "Securities  Exchange Act of 1934", as amended, or
on the national market system of the national  association of securities dealers
automated quotation system, or were held of record by the more than two thousand
shareholders,  at the time of:

      (a)  The  record  date fixed  under  section 7-107-107 to  determine  the
           shareholders entitled to receive notice of the shareholders' meeting
           at which the corporate action is submitted to a vote;

      (b)  The record date fixed under section 7-107-104 to determine
           shareholders entitled to sign writings consenting to the corporate
           action; or

      (c)  The effective date of the corporate action if the corporate action is
           authorized other than by a vote of shareholders.

     (1.8) The  limitation  set forth in subsection  (1.3) of this section shall
not apply if the shareholder will receive for the shareholder's shares, pursuant
to the corporate action, anything except:

      (a)  Shares of the corporation surviving the consummation of the plan of
           merger or share exchange;

      (b)  Shares of any other corporation which at the effective date of the
           plan of merger or share exchange either will be listed on a national
           securities exchange registered under the federal "Securities Exchange
           Act of 1934", as amended, or on the national market system of the
           National Association of Securities Dealers automated quotation system
           or will be held of record by more than two thousand shareholders;

      (c)  Cash in lieu of fractional shares; or

      (d)  Any combination of the foregoing described shares or cash in lieu of
           fractional shares.

     (2) (Deleted by amendment, L.96, p.1321, ss.30, effective June 1, 1996).

     (2.5) A  shareholder,  whether or not  entitled  to vote,  is  entitled  to
dissent and obtain payment of the fair value of the shareholder's  shares in the
event of a  reverse  split  that  reduces  the  number  of  shares  owned by the
shareholder  to a  fraction  of a share or to scrip if the  fractional  share or
scrip so created is to be acquired  for cash or the scrip is to be voided  under
section 7-106-104.

      (3)  A shareholder is entitled to dissent and obtain payment of the fair
           value of the shareholder's shares in the event of any corporate
           action to the extent provided by the bylaws or a resolution of the
           board of directors.

                                       14
<PAGE>

     (4) A  shareholder  entitled  to  dissent  and to  obtain  payment  for the
shareholder's  shares under this article may not challenge the corporate  action
creating  such  entitlement  unless the action is  unlawful or  fraudulent  with
respect to the shareholder or the corporation.

7-113-103. Dissent by nominees and beneficial owners.

     (1) A record shareholder may assert dissenters' rights as to fewer than all
the  shares  registered  in the  record  shareholder's  name only if the  record
shareholder  dissents with respect to all shares  beneficially  owned by any one
person and causes the  corporation  to receive  written notice which states such
dissent and the name, address,  and federal taxpayer  identification  number, if
any, of each person on whose behalf the record shareholder  asserts  dissenters'
rights.  The  rights  of a record  shareholder  under  this  subsection  (1) are
determined as if the shares as to which the record shareholder  dissents and the
other shares of the record shareholder were registered in the names of different
shareholders.

     (2) A beneficial shareholder may assert dissenters' rights as to the shares
held on the beneficial shareholder's behalf only if:

     (a)  The  beneficial  shareholder  causes the  corporation  to receive  the
          record shareholder's written consent to the dissent not later than the
          time the beneficial shareholder asserts dissenters' rights; and

     (b)  The  beneficial  shareholder  dissents  with  respect  to  all  shares
          beneficially owned by the beneficial shareholder.

     (3) The corporation may require that,  when a record  shareholder  dissents
with respect to the shares held by any one or more beneficial shareholders, each
such beneficial  shareholder must certify to the corporation that the beneficial
shareholder  and the record  shareholder  or record  shareholders  of all shares
owned beneficially by the beneficial  shareholder have asserted,  or will timely
assert,  dissenters'  rights  as to all  such  shares  as to  which  there is no
limitation on the ability to exercise  dissenters'  rights. Any such requirement
shall be stated in the dissenters' notice given pursuant to section 7-113-203.

                                     PART 2

                             PROCEDURE FOR EXERCISE
                              OF DISSENTERS' RIGHTS

7-113-201. Notice of dissenters' rights.

     (1) If a  proposed  corporate  action  creating  dissenters'  rights  under
section 7-113-102 is submitted to a vote at a shareholders'  meeting, the notice
of the meeting  shall be given to all  shareholders,  whether or not entitled to
vote. The notice shall state that  shareholders are or may be entitled to assert
dissenters' rights under this article and shall be accompanied by a copy of this
article and the  materials,  if any,  that,  under  articles  101 to 117 of this
title, are required to be given to shareholders  entitled to vote on the propose
action at the meeting. Failure to give notice as provided by this subsection (1)
shall not affect any action  taken at the  shareholders'  meeting  for which the
notice was to have been given,  but any  shareholder who was entitled to dissent


                                       15
<PAGE>

but who was not given such notice shall not be precluded from demanding  payment
for the  shareholder's  shares under this article by reason of the shareholder's
failure to comply with the provisions of section 7-113-202(1).

     (2) If a  proposed  corporate  action  creating  dissenters'  rights  under
section  7-113-102 is authorized  without a meeting of shareholders  pursuant to
section 7-107-104,  any written or oral solicitation of a shareholder to execute
a writing  consenting to such action  contemplated in section 7-107-104 shall be
accompanied or preceded by a written notice stating that shareholders are or may
be entitled to assert dissenters'  rights under this article,  by a copy of this
article,  and by the  materials,  if any, that under articles 101 to 117 of this
title, would have been required to be given to shareholders  entitled to vote on
the  proposed  action  if the  propose  action  were  submitted  to a vote  at a
shareholders' meeting. Failure to give notice as provided by this subsection (2)
shall not affect any action taken  pursuant to section  7-107-104  for which the
notice was to have been given,  but any  shareholder who was entitled to dissent
but who was not given such notice shall not be precluded from demanding  payment
for the  shareholder's  shares under this article by reason of the shareholder's
failure to comply with the provisions of section 7-113-302(2).

7-113-202. Notice of intent to demand payment.

     (1) If a  proposed  corporate  action  creating  dissenters'  rights  under
section  7-113-102  is  submitted  to a vote at a  shareholders'  meeting and if
notice of  dissenters'  rights has been given to such  shareholder in connection
with the action  pursuant to section  7-113-201(1),  a shareholder who wishes to
assert dissenters' rights shall;

      (a)  Cause the corporation to receive, before the vote is taken, written
           notice of the shareholder's intention to demand payment for the
           shareholder's shares if the proposed corporate action is effectuated;
           and

      (b)  Not vote the shares in favor of the proposed corporate action.

     (2) If a  proposed  corporate  action  creating  dissenter's  rights  under
section  7-113-102 is authorized  without a meeting of shareholders  pursuant to
section  7-107-104  and if notice of  dissenter's  rights has been given to such
shareholder in connection  with the action pursuant to section  7-113-201(2),  a
shareholder who wishes to assert  dissenters' rights shall not execute a writing
consenting to the proposed corporate action.

     (3) A shareholder  who does not satisfy the  requirements of subsection (1)
or (2) of this section is not entitled to demand  payment for the  shareholder's
shares under this article.

7-113-203. Dissenters' notice.

     (1) If a  proposed  corporate  action  creating  dissenter's  rights  under
section   7-113-102  is  authorized,   the  corporation  shall  give  a  written
dissenters'  notice to all  shareholders  who are entitled to demand payment for
their shares under this article.

     (2) The dissenters' notice required by subsection (1) of this section shall
be given no later than ten days after the effective date of the corporate action
creating dissenters' rights under section 7-113-102 and shall:

                                       16
<PAGE>

      (a)  State that the corporate action was authorized and state the
           effective date or proposed effective date of the corporate action;

      (b)  State an address at which the corporation will receive payment
           demands and the address of a place where certificates for
           certificated shares must be deposited;

      (c)  Inform holders of uncertificated shares to what extent transfer of
           the shares will be restricted after the payment and demand is
           received;

      (d)  Supply a form for demanding payment, which form shall request a
           dissenter to state an address to which payment is to be made;

      (e)  Set the date by which the corporation must receive the payment demand
           and certificates for certificated shares, which date shall not be
           less than thirty days after the date the notice required by
           subsection (1) of this section is given;

      (f)  State the requirement contemplated in section 7-113-103(3), if such
           requirement is imposed; and

      (g)  Be accompanied by a copy of this article.

7-113-204.   Procedure to demand payment.

     (1) A  shareholder  who is given a dissenters'  notice  pursuant to section
7-113-203 and who wishes to assert  dissenters' rights shall, in accordance with
the terms of the dissenters' notice:

      (a)  Cause the corporation to receive a payment demand, which may be the
           payment demand form contemplated in section 7-113-203(2)(d), duly
           completed, or may be stated in another writing; and

      (b)  Deposit the shareholder's certificates for certificated shares.

     (2) A shareholder  who demands payment in accordance with subsection (1) of
this section  retains all rights of a shareholder,  except the right to transfer
the shares,  until the effective  date of the proposed  corporate  action giving
rise to the shareholder's  exercise of dissenters' rights and has only the right
to receive  payment for the shares after the  effective  date of such  corporate
action.

     (3) Except as provided in section 7-113-207 or 7-113-209(1)(b),  the demand
for payment and deposit of certificates is irrevocable.

     (4) A shareholder who does not demand payment and deposit the shareholder's
share  certificates  as  required  by the date or dates  set in the  dissenters'
notice is not entitled to payment for the shares under this article.

7-113-205.   Uncertificated shares.

     (1) Upon receipt of a demand for payment  under  section  7-113-204  from a
shareholder  holding  uncertificated  shares,  and in  lieu  of the  deposit  of
certificates  representing the shares, the corporation may restrict the transfer
thereof.

                                       17
<PAGE>

     (2) In all other  respects,  the provisions of section  7-113-204  shall be
applicable to shareholders who own uncertificated shares.

7-113-206.   Payment.

     (1) Except as provided in section 7-113-208, upon the effective date of the
corporate action creating  dissenters' rights under section  7-113-102,  or upon
receipt of a payment demand pursuant to section  7-113-204,  whichever is later,
the corporation shall pay each dissenter who complied with section 7-113-204, at
the address stated in the payment demand, or if no such address is stated in the
payment  demand,  at the address shown on the  corporation's  current  record of
shareholders  for the record  shareholder  holding the dissenter's  shares,  the
amount the corporation estimates to be the fair value of the dissenter's shares,
plus accrued interest.

     (2) The payment made  pursuant to  subsection  (1) of this section shall be
accompanied by:

     (a)  The  corporation's  balance  sheet  as of the end of its  most  recent
          fiscal year or, if that is not  available  the  corporation's  balance
          sheet as of the end of a fiscal  year  ending  not more  than  sixteen
          months before the date of payment,  an income statement for that year,
          and,  if the  corporation  customarily  provides  such  statements  to
          shareholders,  a statement of changes in shareholders' equity for that
          year and a statement of cash flow for that year,  which  balance sheet
          and statements shall have been audited if the corporation  customarily
          provides audited financial statements to shareholders,  as well as the
          latest  available  financial  statements,  if any,  for the interim or
          full-year period, which financial statements need not be audited;

     (b)  A  statement  of the  corporation's  estimate of the fair value of the
          shares;

     (c)  An explanation of how the interest was calculated;

     (d)  A statement of the  dissenter's  right to demand payment under section
          7-113-209 and

     (e)  A copy of this article.

7-113-207.    Failure to take action.

     (1) If the effective  date of the  corporate  action  creating  dissenters'
rights under section  7-113-102  does not occur within sixty days after the date
set by the corporation by which the corporation  must receive the payment demand
as provided in section  7-113-203,  the  corporation  shall return the deposited
certificates  and release the transfer  restrictions  imposed on  uncertificated
shares.

     (2) If the effective  date of the  corporate  action  creating  dissenters'
rights under section 7-113-102 occurs more than sixty days after the date set by
the  corporation  by which the  corporation  must receive the payment  demand as
provided in section 7-113-203, then the corporation shall send a new dissenters'
notice,  as  provided  in section  7-113-203,  and the  provisions  of  sections
7-113-204 and 7-113-209 shall again be applicable.

                                       18
<PAGE>

7-113-208. Special provisions relating to shares acquired after announcement of
proposed corporate action.

     (1) The corporation  may, in or with the dissenters'  notice given pursuant
to section 7-113-203,  state the date of the first announcement to news media or
to  shareholders  of  the  terms  of  the  proposed  corporate  action  creating
dissenters'  rights under section  7-113-102 and state that the dissenter  shall
certify in writing,  in or with the  dissenter's  payment  demand under  section
7-114-204,  whether  or not  the  dissenter  (or  the  person  on  whose  behalf
dissenters'  rights are asserted)  acquired  beneficial  ownership of the shares
before  that  date.  With  respect to any  dissenter  who does not so certify in
writing,  in or with the payment  demand,  that the  dissenter  or the person on
whose  behalf the  dissenter  asserts  dissenters'  rights  acquired  beneficial
ownership of the shares before such date, the corporation may, in lieu of making
the payment  provided in section  7-113-206,  offer to make such  payment if the
dissenter agrees to accept it in full satisfaction of the demand.

     (2) An offer to make payment  under  subsection  (1) of this section  shall
include or be accompanied by the information required by section 7-113-206(2).

7-113-209. Procedure if dissenter is dissatisfied with payment or offer.

     (1) A  dissenter  may give  notice to the  corporation  in  writing  of the
dissenter's  estimate  of the fair  value of the  dissenter's  shares and of the
amount of interest due and may demand payment of such estimate, less any payment
made under section  7-113-206,  or reject the corporation's  offer under section
7-113-208  and demand  payment of the fair value of the shares and interest due,
if:

     (a)  The dissenter believes that the amount paid under section 7-113-206 or
          offered  under  section  7-113-208  is less than the fair value of the
          shares or that the interest due was incorrectly calculated;

     (b)  The corporation  fails to make payment under section  7-113-206 within
          sixty  days  after  the  date  set by the  corporation  by  which  the
          corporation must receive the payment demand; or

     (c)  The corporation does not return the deposited  certificates or release
          the transfer restrictions imposed on uncertificated shares as required
          by section 7-113-207(1).

     (2) A  dissenter  waives the right to demand  payment  under  this  section
unless the dissenter  causes the  corporation to receive the notice  required by
subsection (1) of this section within thirty days after the corporation  made or
offered payment for the dissenter's shares.

                                     PART 3

                          JUDICIAL APPRAISAL OF SHARES

7-113-301. Court action.

     (1) If a demand for payment under section 7-113-209 remains unresolved, the
corporation may, within sixty days after receiving the payment demand commence a
proceeding  and petition the court to determine the fair value of the shares and
accrued interest. If the corporation does not commence the proceeding within the
sixty-day period, it shall pay to each dissenter whose demand remains unresolved
the amount demanded.

                                       19
<PAGE>

     (2) The corporation  shall commence the proceeding  described in subsection
(1) of this section in the district  court for the county in this state in which
the street address of the  corporation's  principal office is located or, if the
corporation has no principal office in this state, in the district court for the
county in which the street  address of its registered  agent is located,  or, if
the corporation has no registered  agent, in the district court for the city and
county  of  Denver.  If the  corporation  is a  foreign  corporation  without  a
registered  agent,  it shall  commence  the  proceeding  in the  county in which
domestic  corporation  merged into, or whose shares were acquired by the foreign
corporation would have commenced the action that corporation were subject to the
first sentence of this subsection (2).

     (3) The corporation shall make all dissenters,  whether or not residents of
this state, whose demands remain unresolved parties to the proceeding  commenced
under  subsection (2) of this section as in an action against their shares,  and
all  parties  shall  be  served  with a copy of the  petition.  Service  on each
dissenter  shall be by  registered or certified  mail, to the address  stated in
such dissenter's  payment demand, or if no such address is stated in the payment
demand, at the address shown on the corporation's current record of shareholders
for the record  shareholder  holding the dissenter's  shares,  or as provided by
law.

     (4) The  jurisdiction  of the court in which the  proceeding  is  commenced
under  subsection  (2) of this section in plenary and  exclusive.  The court may
appoint one or more persons as  appraisers  to receive  evidence and recommend a
decision on the question of fair value. The appraisers have the powers described
in the order  appointing them, or in any amendment to such order. The parties to
the  proceeding  are entitled to the same  discovery  rights as parties in other
civil proceedings.

     (5)  Each  dissenter  made  a  party  to  the  proceeding  commenced  under
subsection (2) of this section is entitled to judgement for the amount,  if any,
by which  the  court  finds  the  fair  value of the  dissenter's  shares,  plus
interest,  exceeds  the amount paid by the  corporation,  or for the fair value,
plus interest,  of the dissenter's  shares for which the corporation  elected to
withhold payment under section 7-113-208.

7-113-302. Court costs and counsel fees.

     (1) The court in an appraisal  proceeding commenced under section 7-113-301
shall  determine  all  costs  of  the   proceeding,   including  the  reasonable
compensation and expenses of appraisers  appointed by the court. The court shall
assess the costs against the corporation; except that the court may assess costs
against all or some of the dissenters,  in amounts the court finds equitable, to
the extent the court finds the dissenters acted arbitrarily, vexatiously, or not
in good faith in demanding payment under section 7-113-209.

     (2) The court may also assess the fees and  expenses of counsel and experts
for the respective parties, in amounts the court finds equitable:

     (a)  Against the  corporation  and in favor of any  dissenters if the court
          finds the corporation did not substantially comply with part 2 of this
          article; or

     (b)  Against either the corporation or one or more dissenters,  in favor of
          any other  party,  if the court finds that the party  against whom the


                                       20
<PAGE>

          fees and expenses are assessed acted arbitrarily,  vexatiously, or not
          in good faith with respect to the rights provided by this article.

     (3) If the court finds that the services of counsel for any dissenter  were
of substantial benefit to other dissenters similarly situated, and that the fees
for those services should not be assessed against the corporation, the court may
award to said counsel  reasonable  fees to be paid out of the amounts awarded to
the dissenters who were benefitted.



                                       21
<PAGE>

                              ADVANTEGO CORPORATION
               NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS

     Important  Notice  Regarding the  Availability  of Proxy  Materials for the
Special Shareholder's Meeting to Be Held on March 6, 2020.

     1.   This notice is not a form for voting.

     2.   This  communication  presents  only an overview  of the more  complete
          proxy  materials  that  are  available  to  you on  the  Internet.  We
          encourage  you to access and review all of the  important  information
          contained in the proxy materials before voting.

     3.   The Notice of the Special  Meeting of  Shareholders  and related Proxy
          Statement are available at www.advantego.com/investor.

     4.   If you want to receive a paper or email copy of these  documents,  you
          must  request  one.  There is no charge to you for  requesting a copy.
          Please make your request for a copy as  instructed  below on or before
          February 14, 2020 to facilitate timely delivery.

     The special  meeting of the Company's  shareholders  will be held at 1 Park
Plaza,  Suite 600, Large Conference Room,  Irvine,  CA 92614 on March 6, 2020 at
10:00 a.m. Pacific Time, for the following purposes:

     (1) to approve amendments to the Company's Articles of Incorporation;

          (i)  to reduce the quorum required at shareholders' meetings; and

          (ii) to  allow  shareholders   owning  a  majority  of  the  Company's
               outstanding shares to approve actions without a meeting;

     (2) to approve a reverse  split of the Company's  common stock,  should the
board of  directors  believe this to be in the best  interests of the  Company's
shareholders,  in a ratio  that will be  determined  by the  Company's  board of
directors.

     (3) to approve an amendment to the Company's  Articles of  Incorporation to
increase the Company's authorized capitalization to 300 billion shares of common
stock.

     The  Board  of  Directors   recommends  that   shareholders  vote  FOR  the
aforementioned proposals.

     January 20, 2020 is the record date for the  determination  of shareholders
entitled  to  notice of and to vote at the  meeting.  Holders  of the  Company's
common stock and Series B preferred stock may cast one vote for each share held.
Holders of the  Company's  Series A preferred  stock are entitled to 1,000 votes
per share at the special meeting of shareholders.


                                       22
<PAGE>

     Shareholders may access the following documents at www.advantego.com/
investor:

          o    Notice of the Special Meeting of Shareholders;
          o    Company's Proxy Statement;
          o    Proxy Card; and
          o    December 31, 2018 10-K report.

    Shareholders may request a paper copy of the Proxy Materials and Proxy Card
by calling (949)627-8977, by emailing the Company at shareholders@advantego.com,
or by visiting www.advantego.com/investor and indicating if you want a paper
copy of the proxy materials and proxy card:

          o    for this meeting only; or
          o    for this meeting and all other meetings.

     If you have a stock  certificate  registered in your name, or if you have a
proxy from a  shareholder  of record on January  20,  2020 you can,  if desired,
attend  the  special  meeting  and  vote  in  person.  Shareholders  can  obtain
directions     to    the    2020     special     shareholders'     meeting    at
www.advantego.com/investor.

      Please visit www.advantego.com/investor to print and fill out the Proxy
Card. Complete and sign the proxy card and mail the Proxy Card to:


                              Advantego Corporation
                             1 Park Plaza, Suite 600
                                Irvine, CA 92614
                                 (949) 627-8977



                                       23
<PAGE>
                                      PROXY

                              ADVANTEGO CORPORATION
           This Proxy is solicited by the Company's Board of Directors

The undersigned stockholder of the Company acknowledges receipt of the Notice of
the Special  Meeting of  Stockholders  to be at 1 Park Plaza,  Suite 600,  Large
Conference Room,  Irvine,  CA 92614, and hereby appoints Robert W. Ferguson with
the power of  substitution,  as Attorney and Proxy to vote all the shares of the
undersigned  at said special  meeting of  stockholders  and at all  adjournments
thereof, hereby ratifying and confirming all that said Attorney and Proxy may do
or cause to be done by virtue hereof.  The Special Meeting will be held at 10:00
a.m.  (Pacific Time) on March 6, 2020. The above named Attorneys and Proxies are
instructed to vote all of the undersigned's shares as follows:

(1)  to reduce the quorum required at shareholders' meetings;

                   [ ] FOR       [ ] AGAINST     [ ]  ABSTAIN

(2)  to allow shareholders owning a majority of the Company's outstanding shares
     to approve actions without a meeting;

                   [ ] FOR       [ ] AGAINST     [ ]  ABSTAIN

(3)  to approve a reverse split of the Company's common stock,  should the board
     of  directors  believe this to be in the best  interests  of the  Company's
     shareholders,  in a ratio that will be determined by the Company's board of
     directors; and

                   [ ] FOR       [ ] AGAINST     [ ]  ABSTAIN

(4)   to approve an amendment to the Company's Articles of Incorporation to
      increase the Company's authorized capitalization to 300 billion shares of
      common stock.

                   [ ] FOR       [ ] AGAINST     [ ]  ABSTAIN

    to transact such other business as may come before the meeting.

THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED HEREIN BY THE
UNDERSIGNED STOCKHOLDER IF NO DISCRETION IS INDICATED, THIS PROXY WILL BE VOTED
IN FAVOR OF ITEMS 1-4.

Dated this ____ day of _______, 2020.

                                       ---------------------------------------
                                       (Signature)

                                       ---------------------------------------
                                       (Print Name)

    Please sign your name exactly as it appears on your stock certificate. If
                shares are held jointly, each holder should sign.
   Executors, trustees, and other fiduciaries should so indicate when signing.
   Please Sign, Date and Return this Proxy so that your shares may be voted at
                                  the meeting.

              Send your proxy by regular mail, email, or fax to:

                          Advantego Technologies, Inc.
                             Attn: Legal Department
                             1 Park Plaza, Suite 600
                                Irvine, CA 92614
                                 (949) 627-8977
                        Email: shareholders@advantego.com
                               Fax: (949) 272-0059

A
